Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease

Bone Marrow Transplantation, Published online: 06 November 2023; doi:10.1038/s41409-023-02144-8Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease

Source: Bone Marrow Transplantation - November 6, 2023 Category: Hematology Authors: Lennart Philippen Natalie Schub Andreas G ünther Gunnar Cario Martin Schrappe Roland Repp Martin Gramatzki Source Type: research